Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Mibampator (LY451395) | 375345-95-2 | 99.5% | 438.60 | 100 MG
SDP

Catalog No. 5000345198
Encompass_Preferred

Mibampator (LY451395) is a potent and highly selective potentiator of the AMPA receptors, intended for research use only. It has shown various cellular effects, including toxicity against Caco-2 cells and inhibition of SARS-CoV-2 induced cytotoxicity. In vivo studies indicated its ability to reverse ethanol-induced deficits in rats. It has also undergone Phase 2 clinical trials for Alzheimer's Disease.

  • Potent and highly selective potentiator of AMPA receptors
  • Caco-2 CC50 of 8.66 μM and IC50 of 3.28 μM
  • HEK293 EC50 of 0.15 μM
  • Reverses central effects of acutely intoxicating dose of ethanol in rats
  • Clinical trials for Alzheimer's Disease

Catalog No. 50-003-45198 Supplier Medchemexpress LLC Supplier No. HY1093410MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mibampator (LY451395) is a potent and highly selective potentiator of the AMPA receptors, intended for research use only. It has shown various cellular effects, including toxicity against Caco-2 cells and inhibition of SARS-CoV-2 induced cytotoxicity. In vivo studies indicated its ability to reverse ethanol-induced deficits in rats. It has also undergone Phase 2 clinical trials for Alzheimer's Disease.

  • Potent and highly selective potentiator of AMPA receptors
  • Caco-2 CC50 of 8.66 μM and IC50 of 3.28 μM
  • HEK293 EC50 of 0.15 μM
  • Reverses central effects of acutely intoxicating dose of ethanol in rats
  • Clinical trials for Alzheimer's Disease

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.